Biohaven (BHVN) Cash from Investing Activities (2021 - 2026)

Biohaven has disclosed Cash from Investing Activities across 6 years of filings, most recently posting $15.2 million for Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at $15.2 million, down 90.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $150.9 million (up 232.22% YoY), and the FY2025 annual result was $300.6 million, up 222.69% from the prior year.
• Cash from Investing Activities came in at $15.2 million for Q1 2026 at Biohaven, up from -$13.7 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $165.0 million in Q3 2025 to a low of -$264.0 million in Q4 2022.
• The 5-year median for Cash from Investing Activities is -$3.9 million (2023), against an average of -$6.1 million.
• Across the five-year window, Cash from Investing Activities tumbled 131251.24% in 2022 and jumped 3313.5% in 2024, its largest moves.
• Biohaven's Cash from Investing Activities stood at -$264.0 million in 2022, then surged by 98.52% to -$3.9 million in 2023, then plunged by 2140.06% to -$87.7 million in 2024, then soared by 84.33% to -$13.7 million in 2025, then surged by 210.72% to $15.2 million in 2026.
• The last three Cash from Investing Activities figures came in at $15.2 million (Q1 2026), -$13.7 million (Q4 2025), and $165.0 million (Q3 2025), per Business Quant data.